1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE
|
|
- CAS-Nr.
- 163042-96-4
- Englisch Name:
- 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE
- Synonyma:
- CF-102;Netazepide;Cl-IB-MECA;CS-649;CI-IB-MECA;2-CL-IB-MECA;CF102 Namodenoson;Namodenoson CF102;CF-102(2-Cl-IB-MECA);2-Cl-IB-MECA (CF-102)
- CBNumber:
- CB7283143
- Summenformel:
- C18H18ClIN6O4
- Molgewicht:
- 544.73
- MOL-Datei:
- 163042-96-4.mol
|
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE Eigenschaften
- Schmelzpunkt:
- 209 °C
- Dichte
- 2.04±0.1 g/cm3 (20 ºC 760 Torr)
- storage temp.
- Keep in dark place,Inert atmosphere,2-8°C
- L?slichkeit
- DMSO: >20mg/mL
- Aggregatzustand
- solid
- pka
- 12.68±0.70(Predicted)
- Farbe
- white
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Verwenden
2-Cl-IB-MECA acts as an A3 adenosine receptor-selective nucleoside.
Biologische Aktivit?t
High affinity and extremely selective A 3 adenosine receptor agonist (K i = 0.33 nM). Displays 2500- and 1400-fold selectivity over A 1 and A 2A receptors respectively. Exhibits high selectivity over the Na + -independent adenosine transporter.
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 139)Lieferanten
163042-96-4()Verwandte Suche:
- 2-CL-IB-MECA
- 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE
- 1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-(9H)-purin-9-yl)-1-deoxy-N-methyl-beta-D-ribofuranuronamide
- Cl-IB-MECA, 2-Chloro-N6-(3-iodobenzyl)-adenosine-5μ-N-methyluronamide
- 1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide
- 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-β-D-RIBOFURANURONAMIDE
2-Cl-IB-Meca
- b-D-RibofuranuronaMide,1-[2-chloro-6-[[(3-iodophenyl)Methyl]aMino]-9H-purin-9-yl]-1-deoxy-N-Methyl-
- (2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)aMino)-9H-purin-9-yl)-3,4-dihydroxy-N-Methyltetrahydrofuran-2-carboxaMide
- 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-D-ribofuranuronamide
- CI-IB-MECA
- 2-Cl-IB-MECA (CF-102)
- CS-649
- CF102; CF-102; CF 102; CL-IB-MECA; 2-CL-IB-MECA
- CF102 Namodenoson
- CF-102(2-Cl-IB-MECA)
- β-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-
- Namodenoson CF102
- (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
- Namodenoson (2 Cl-IB-MECA
- Netazepide
- Cl-IB-MECA
- CF-102
- 163042-96-4
- 1-?[2-?chloro-?6-?[[(3-?iodophenyl)?methyl]?amino]?-?9H-?purin-?9-?yl]?-?1-?deoxy-?N-?methyl-β-?D-?Ribofuranuronamide
- Namodenoson, 10 mM in DMSO
- 163042-96-4
- C18H18ClIN6O4